查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1632614

全球臨床實驗試驗生物庫和檔案解決方案市場：市場規模、佔有率和趨勢分析（按服務、產品、階段、地區和細分市場，2025-2030 年）

Clinical Trial Biorepository & Archiving Solutions Market Size, Share & Trends Analysis Report By Service (Biorepository Services, Archiving Solution Services), By Product, By Phase, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 192 Pages | 商品交期: 2-10個工作天內

價格

臨床實驗生物庫和檔案解決方案市場的成長和趨勢：

根據Grand View Research, Inc.的最新報告，全球臨床實驗試驗生物庫和檔案解決方案市場規模預計到2030年將達到70.1億美元，2025年至2030年期間的複合年成長率為8.18%。

這主要是因為生物樣本管理在臨床實驗試驗中的重要性日益增加，以及簡化資料收集和報告的意願。此外，精準醫療、個人化醫療和基因組醫學的擴展、研發支出的增加、以及透過採用 LIMS（實驗室資訊管理系統）等軟體進行實驗室樣本管理以促進資料收集和報告的努力都是推動該行業成長的關鍵因素。

一些監管機構為生物樣本庫的運作提供了建議並制定了最佳實踐。國際生物和環境檔案協會正在加強其在全球範圍內標準化生物檔案程序方面的地位。美國病理學家學院建立了第一個生物樣本庫設施認證計劃，該計劃遵守嚴格的規定，以規範生物樣本庫設施的實踐。國際標準化組織（ISO-20387）發布了生物保存設施標準，以確保生物保存能力、公平性和一致性運作。

美國FDA制定了良好生產規範（GMP）、良好實驗室規範（GLP）、GDP、良好組織規範（GTP），其中包含了與藥品包裝和儲存相關的要素。此外，新冠疫情也為當地企業創造了許多成長機會。為了在行業中站穩腳跟，主要企業正在採取各種計劃和政策，以在全球市場上搶佔更大的收益佔有率。作為重要一步，主要企業可以與相關的第三方供應商建立合作關係。這可以透過適當的溝通和協調臨床實驗試驗生物庫和歸檔解決方案的頻率和數量來實現。

臨床實驗生物庫和檔案解決方案市場：分析概述

  • 2024 年，生物檢體資料庫服務部門將佔據市場主導地位，佔 66.91% 的收益佔有率。該領域的成長主要得益於再生醫學、個人化醫療和癌症基因組學研究等先進療法的研究和開發不斷增加，這些療法需要有效的儲存、分配和處理解決方案。
  • 根據產品，市場分為臨床前產品和臨床產品。 2024 年，臨床產品部門在臨床實驗生物庫和檔案解決方案市場中佔據最大收益佔有率，為 63.40%。
  • 依階段，市場分為臨床前、第一階段、第二階段、第三階段、第四階段。臨床前部分在 2024 年佔據最大的收益佔有率，為 36.60%。該領域的成長可歸因於對資料完整性和透明度的日益重視。
  • 2024 年北美臨床實驗生物庫和檔案解決方案市場佔有最大佔有率，為 47.99%。臨床試驗數量的不斷增加以及希望擴展現有服務的眾多市場參與者進一步促進了臨床實驗試驗生物庫和歸檔解決方案的成長。

目錄

第1章 分析方法及範圍

第 2 章執行摘要

第 3 章臨床實驗生物庫和檔案解決方案市場：促進因素、趨勢和範圍

  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 臨床實驗生物庫和檔案解決方案市場：分析工具
    • 產業分析：波特五力分析
    • PESTEL 分析
    • COVID-19影響分析

第 4 章臨床實驗生物庫和檔案解決方案市場：按服務進行的估計和趨勢分析

  • 全球臨床實驗試驗生物庫和檔案解決方案市場：細分儀表板（按服務分類）
  • 全球臨床實驗試驗生物庫和檔案解決方案市場：按服務進行變化分析
  • 依服務分類（2018-2030 年）
  • 生物檢體資料庫服務
    • 生物檢體資料庫服務市場（2018-2030）
    • 倉庫存放
    • 送貨
    • 樣品處理
    • 其他
  • 歸檔解決方案服務
    • 檔案解決方案服務市場（2018-2030）
    • 資料庫索引的建立和管理
    • 掃描並銷毀

第 5 章臨床實驗生物庫和檔案解決方案市場：按產品分類的估計和趨勢分析

  • 全球臨床實驗試驗生物庫和檔案解決方案市場：細分儀表板（按產品分類）
  • 全球臨床實驗試驗生物庫和檔案解決方案市場：按產品進行變化分析
  • 按產品（2018 - 2030 年）
  • 臨床前產品
    • 臨床前產品市場（2018-2030）
  • 臨床產品
    • 臨床產品市場（2018-2030）
    • 人體組織
    • 器官
    • 幹細胞
    • 其他生物檢體

第6章臨床實驗生物庫和檔案解決方案市場：各階段的估計和趨勢分析

  • 全球臨床實驗試驗生物庫和檔案解決方案市場：細分儀表板，按階段分類
  • 全球臨床實驗生物庫和檔案解決方案市場：按階段進行數量分析
  • 階段（2018-2030）
  • 臨床前
    • 臨床前市場（2018-2030）
  • 第一階段
    • 第一階段市場（2018-2030年）
  • 第二階段
    • 第二階段市場（2018-2030年）
  • 第三階段
    • 第三階段市場（2018-2030年）
  • 第四階段
    • 第四階段市場（2018-2030年）

第 7 章臨床實驗生物庫和檔案解決方案市場：區域估計和趨勢分析

  • 按地區分類的市場佔有率分析（2024 年和 2030 年）
  • 市場儀表板：按地區
  • 全球市場概況：按地區
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 市場參與企業分類
  • 公司市場佔有率分析（2023/24）
  • 公司簡介
    • Medpace
    • American Type Culture Collection (ATCC)
    • Cell&Co BioServices (Cryoport)
    • Brooks Life Sciences (Azenta, Inc.)
    • Patheon (Thermo Fisher Scientific, Inc.)
    • Precision Medicine Group, LLC.
    • Labcorp Drug Development
    • Q2 Solutions
    • LabConnect
    • Charles River Laboratories

第9章 主要建議

Product Code: GVR-4-68039-532-8

Clinical Trial Biorepository & Archiving Solutions Market Growth & Trends:

The global clinical trial biorepository & archiving solutions market size is expected to reach USD 7.01 billion by 2030, registering a CAGR of 8.18% from 2025 to 2030, according to a new report by Grand View Research, Inc. This is mainly due to the increasing importance of biological sample management in clinical trials and the desire to streamline data collection and reporting. In addition, the expansion of precision, personalized, and genomic medicine, increased R&D spending and efforts to make data gathering & reporting easier by employing software like the Laboratory Information Management System (LIMS) to manage laboratory samples are all key factors driving the industry growth.

Multiple regulatory agencies advise and develop best practices in biorepository operations. The International Society for Biological and Environmental Repositories has strengthened its position in the standardization of bio-storage procedures on a global level. The College of American Pathologists established the first biorepository accreditation scheme that adheres to stringent regulations to standardize biorepository practices. Biorepository standards for competence, impartiality, and consistent operation for bio storage have been issued by the International Organization for Standardization (ISO-20387).

The U.S. FDA has established Good Manufacturing Practice (GMP), Good Laboratory Practice (GLP), GDP, and Good Tissue Practice (GTP), which contain the elements associated with the packing and storage of drug products. In addition, the COVID-19 pandemic has created several growth opportunities for local companies. To enhance their foothold in the industry, key companies are adopting various plans and policies to gain a more significant revenue share in the global market. The important step key players can incorporate partnering with relevant third-party vendors. It can be achieved through proper communication and adjustments in the frequency and volume of clinical trial biorepository and archiving solutions.

Clinical Trial Biorepository & Archiving Solutions Market Report Highlights:

  • In 2024, the biorepository services segment dominated the market, accounting for a revenue share of 66.91%. The segment growth can be attributed to the rise in R&D of advanced therapies, such as regenerative medicine, personalized medicine, and cancer genomic studies, which require effective storage, distribution, and processing solutions.
  • On the basis of the product segment, the market is segmented into preclinical products and clinical products. In 2024, the clinical products segment accounted for the largest revenue share of 63.40% in the clinical trial biorepository & archiving solutions market.
  • On the basis of phase segment, the market is segmented to preclinical, phase I, phase II, phase III, and phase IV. The preclinical segment accounted for the largest revenue share of 36.60% in 2024. The segment growth can be growing emphasis on data integrity & transparency.
  • North America clinical trial biorepository & archiving solutions market accounted for the largest share of 47.99% in 2024. The increase in the number of clinical trials and several market players in the region aiming to expand their existing services are further contributing to the growth of clinical trial biorepository & archiving solutions.

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Service
    • 1.2.2. Product
    • 1.2.3. Phase
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Parent Market Analysis
  • 1.8. List Of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Clinical Trial Biorepository & Archiving Solutions Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing number of pharmaceutical and biotechnology companies
      • 3.2.1.2. Growing disease variation and prevalence
      • 3.2.1.3. Increasing R&D investments
      • 3.2.1.4. Growth in the CRO market
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Regulations for new drug development
      • 3.2.2.2. Rising cost of clinical trials
  • 3.3. Clinical Trial Biorepository & Archiving Solutions Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Clinical Trial Biorepository & Archiving Solutions Market: Service Estimates & Trend Analysis

  • 4.1. Clinical Trial Biorepository & Archiving Solutions Market, By Service: Segment Dashboard
  • 4.2. Clinical Trial Biorepository & Archiving Solutions Market, By Service: Movement Analysis
  • 4.3. Clinical Trial Biorepository & Archiving Solutions Market Estimates & Forecasts, By Service, 2018 - 2030
  • 4.4. Biorepository Services
    • 4.4.1. Biorepository Services Market, 2018 to 2030 (USD Million)
    • 4.4.2. Warehousing & Storage
      • 4.4.2.1. Warehousing & Storage Market, 2018 to 2030 (USD Million)
    • 4.4.3. Transportation
      • 4.4.3.1. Transportation Market, 2018 to 2030 (USD Million)
    • 4.4.4. Sample Processing
      • 4.4.4.1. Sample Processing Market, 2018 to 2030 (USD Million)
    • 4.4.5. Others
      • 4.4.5.1. Others Market, 2018 to 2030 (USD Million)
  • 4.5. Archiving Solution Services
    • 4.5.1. Archiving Solution Services Market, 2018 to 2030 (USD Million)
    • 4.5.2. Database Indexing and Management
      • 4.5.2.1. Database Indexing and Management Market, 2018 to 2030 (USD Million)
    • 4.5.3. Scanning & Destruction
      • 4.5.3.1. Scanning & Destruction Market, 2018 to 2030 (USD Million)

Chapter 5. Clinical Trial Biorepository & Archiving Solutions Market: Product Estimates & Trend Analysis

  • 5.1. Clinical Trial Biorepository & Archiving Solutions Market, By Product: Segment Dashboard
  • 5.2. Clinical Trial Biorepository & Archiving Solutions Market, By Product: Movement Analysis
  • 5.3. Clinical Trial Biorepository & Archiving Solutions Market Estimates & Forecasts, By Product, 2018 - 2030
  • 5.4. Preclinical Products
    • 5.4.1. Preclinical Products Market, 2018 to 2030 (USD Million)
  • 5.5. Clinical Products
    • 5.5.1. Clinical Products Market, 2018 to 2030 (USD Million)
    • 5.5.2. Human Tissue
      • 5.5.2.1. Human Tissue Market, 2018 to 2030 (USD Million)
    • 5.5.3. Organs
      • 5.5.3.1. Organs Market, 2018 to 2030 (USD Million)
    • 5.5.4. Stem Cells
      • 5.5.4.1. Stem Cells Market, 2018 to 2030 (USD Million)
    • 5.5.5. Other Biospecimens
      • 5.5.5.1. Other Biospecimens Market, 2018 to 2030 (USD Million)

Chapter 6. Clinical Trial Biorepository & Archiving Solutions Market: Phase Estimates & Trend Analysis

  • 6.1. Clinical Trial Biorepository & Archiving Solutions Market, By Phase: Segment Dashboard
  • 6.2. Clinical Trial Biorepository & Archiving Solutions Market, By Phase: Movement Analysis
  • 6.3. Clinical Trial Biorepository & Archiving Solutions Market Estimates & Forecasts, By Phase, 2018 - 2030
  • 6.4. Preclinical
    • 6.4.1. Preclinical conditions Market, 2018 to 2030 (USD Million)
  • 6.5. Phase I
    • 6.5.1. Phase I Market, 2018 to 2030 (USD Million)
  • 6.6. Phase II
    • 6.6.1. Phase II Market, 2018 to 2030 (USD Million)
  • 6.7. Phase III
    • 6.7.1. Phase III Market, 2018 to 2030 (USD Million)
  • 6.8. Phase IV
    • 6.8.1. Phase IV Market, 2018 to 2030 (USD Million)

Chapter 7. Clinical Trial Biorepository & Archiving Solutions Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. North America
    • 7.4.1. North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. U.S
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competitive Scenario
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Company Market Share Analysis, 2023/24
  • 8.3. Company Profiles
    • 8.3.1. Medpace
      • 8.3.1.1. Company Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Service Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. American Type Culture Collection (ATCC)
      • 8.3.2.1. Company Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Service Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. Cell&Co BioServices (Cryoport)
      • 8.3.3.1. Company Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Service Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. Brooks Life Sciences (Azenta, Inc.)
      • 8.3.4.1. Company Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Service Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. Patheon (Thermo Fisher Scientific, Inc.)
      • 8.3.5.1. Company Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Service Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. Precision Medicine Group, LLC.
      • 8.3.6.1. Company Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Service Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. Labcorp Drug Development
      • 8.3.7.1. Company Overview
      • 8.3.7.2. Financial Performance
      • 8.3.7.3. Service Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. Q2 Solutions
      • 8.3.8.1. Company Overview
      • 8.3.8.2. Financial Performance
      • 8.3.8.3. Service Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. LabConnect
      • 8.3.9.1. Company Overview
      • 8.3.9.2. Financial Performance
      • 8.3.9.3. Service Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. Charles River Laboratories
      • 8.3.10.1. Company Overview
      • 8.3.10.2. Financial Performance
      • 8.3.10.3. Service Benchmarking
      • 8.3.10.4. Strategic Initiatives

Chapter 9 Key Recommendations

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 North America Clinical Trial Biorepository & Archiving Solutions market, by region, 2018 - 2030 (USD Million)
  • Table 4 North America Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 5 North America Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 6 North America Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 7 U.S. Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 8 U.S. Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 9 U.S. Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 10 Canada Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 11 Canada Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 12 Canada Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 13 Mexico Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 14 Mexico Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 15 Mexico Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 16 Europe Clinical Trial Biorepository & Archiving Solutions market, by region, 2018 - 2030 (USD Million)
  • Table 17 Europe Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 18 Europe Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 19 Europe Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 20 UK Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 21 UK Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 22 UK Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 23 Germany Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 24 Germany Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 25 Germany Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 26 France Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 27 France Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 28 France Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 29 Italy Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 30 Italy Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 31 Italy Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 32 Spain Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 33 Spain Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 34 Spain Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 35 Denmark Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 36 Denmark Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 37 Denmark Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 38 Sweden Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 39 Sweden Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 40 Sweden Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 41 Norway Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 42 Norway Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 43 Norway Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific Clinical Trial Biorepository & Archiving Solutions market, by region, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 48 Japan Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 49 Japan Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 50 Japan Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 51 China Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 52 China Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 53 China Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 54 India Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 55 India Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 56 India Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 57 Australia Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 58 Australia Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 59 Australia Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 60 South Korea Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 61 South Korea Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 62 South Korea Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 63 Thailand Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 64 Thailand Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 65 Thailand Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 66 Latin America Clinical Trial Biorepository & Archiving Solutions market, by region, 2018 - 2030 (USD Million)
  • Table 67 Latin America Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 68 Latin America Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 69 Latin America Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 70 Brazil Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 71 Brazil Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 72 Brazil Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 73 Argentina Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 74 Argentina Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 75 Argentina Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 76 Colombia Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 77 Colombia Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 78 Colombia Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa Clinical Trial Biorepository & Archiving Solutions market, by region, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 83 South Africa Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 84 South Africa Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 85 South Africa Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 89 UAE Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 90 UAE Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 91 UAE Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 92 Kuwait Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Clinical trial biorepository & archiving solutions market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Commodity flow analysis
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD model sizing & forecasting
  • Fig. 10 Bottom-up approach
  • Fig. 11 Market snapshot
  • Fig. 12 Segment snapshot 1
  • Fig. 13 Segment snapshot 2
  • Fig. 14 Competitive landscape snapshot
  • Fig. 15 Parent market outlook, 2023 (USD Billion)
  • Fig. 16 Ancillary market outlook, 2023 (USD Billion)
  • Fig. 17 Clinical trial biorepository & archiving solutions market dynamics
  • Fig. 18 Porter's five forces analysis
  • Fig. 19 PESTEL analysis
  • Fig. 20 Clinical trial biorepository & archiving solutions market: Service outlook and key takeaways
  • Fig. 21 Clinical Trial Biorepository & Archiving Solutions market: Service movement analysis
  • Fig. 22 Biorepository services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Warehousing & storage market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Transportation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Sample processing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Others biorepository services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Archiving solution services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Database indexing & management market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Scanning & destruction market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Clinical Trial Biorepository & Archiving Solutions market: Product outlook and key takeaways
  • Fig. 31 Clinical Trial Biorepository & Archiving Solutions market: Product movement analysis
  • Fig. 32 Preclinical products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Clinical products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Human tissue market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Organs market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Stem cells market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Other biospecimens market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Clinical Trial biorepository & archiving solutions market: Phase outlook and key takeaways
  • Fig. 39 Clinical trial biorepository & archiving solutions market: Phase movement analysis
  • Fig. 40 Preclinical market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Phase I market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Phase II market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Phase III market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Phase IV market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Regional Marketplace: Key Takeaways
  • Fig. 46 North America clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 U.S. clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Canada clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Mexico clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Europe clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 UK clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 Germany clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 France clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Italy clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Spain clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Denmark clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 Sweden clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Norway clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Asia Pacific clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 China clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 India clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 Japan clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 Australia clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 South Korea clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Thailand clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Latin America clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 Brazil clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 Argentina clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 Colombia clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 MEA clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Key country dynamics
  • Fig. 92 South Africa clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 Fig. Key country dynamics
  • Fig. 94 Saudi Arabia clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 UAE clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 97 Key country dynamics
  • Fig. 98 Kuwait clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 99 Key company categorization
  • Fig. 100 Service heat map analysis
  • Fig. 101 Strategic framework